Summit Therapeutics (SMMT) Other Operating Expenses (2017 - 2024)

Summit Therapeutics (SMMT) has 8 years of Other Operating Expenses data on file, last reported at $205000.0 in Q4 2024.

• Quarterly Other Operating Expenses rose 14.53% year-over-year to $205000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $205000.0 (down 28.57% YoY) and the FY2024 annual result came in at $313000.0, down 68.73% from the prior year.
• Other Operating Expenses improved to $205000.0 in Q4 2024, from -$264000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $6.8 million in Q1 2020 to a low of -$264000.0 in Q3 2024.
• A 5-year average of $2.8 million and a median of $3.4 million in 2020 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 688.89% in 2024, down 199.62% in 2024.
• Tracing SMMT's Other Operating Expenses over 5 years: stood at $4.4 million in 2020, then climbed by 5.18% to $4.6 million in 2021, then sank by 75.31% to $1.1 million in 2022, then sank by 84.2% to $179000.0 in 2023, then gained by 14.53% to $205000.0 in 2024.
• The last three Other Operating Expenses figures came in at $205000.0 (Q4 2024), -$264000.0 (Q3 2024), and $159000.0 (Q2 2024), per Business Quant data.